Concepedia

Stephen Saletan

SS

15

Publications

871

Citations

12

H-Index

1982

Active since

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Cedars-Sinai Medical Center

Cornell University

Institut Gustave Roussy

Stephen Saletan is an author at Novartis (United States) specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1982–2014

15

Publications

15

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.

Z Arlin, Delvyn C. Case, J. Moore et al. · PubMed · 1990 · 199 citations

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Advanced Lung Neuroendocrine Tumors

Nicola Fazio, Ashley Grossman, Stephen Saletan et al. · CHEST Journal · 2013 · 123 citations

, , +4

Amphotericin B Lipid Complex (Ablc™): A Molecular Rationale for the Attenuation of Amphotericin B Related Toxicities

A S Janoff, Walter R. Perkins, Stephen Saletan et al. · Journal of Liposome Research · 1993 · 121 citations

, , +15

A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer

Shannon Cope, Jie Zhang, Stephen Saletan et al. · BMC Medicine · 2014 · 116 citations · Full text

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

Daniel Castellano, Emilio Bajetta, Ashok Panneerselvam et al. · The Oncologist · 2012 · 66 citations · Full text

Rows per page

1–5 of 15